The French drug maker, which develops vaccines and other pharmaceuticals and is currently working on a vaccine to combat bird flu, selected the two-story site because it gave the company a full, stand-alone building just blocks from MIT, a broker involved in the sale who did not want to be identified tells GlobeSt.com. The company is currently located at 26 Lansdowne St. here.
Porter McMillian, senior vice president of US Science & Medical Affairs for sanofi-aventis, says in a statement the expansion along with the developing technologies from nearby colleges and universities will help the firm meet its research and development goals. Dan Loughlin with the Staubach Co. in New Jersey and Greg Zais with Staubach in Boston brokered the deal for the tenant. The building's owner, Biomed Realty Trust, was self-represented.
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.